The Essential Role of Real World Evidence Combating COVID-19
Are you prepared for potential accelerated approval requirements?
Patient & Physician Services Recognized Again for Excellence in Healthcare Advertising and Marketing
Once again, UBC’s Patient & Physician Services (PPS) Creative Services Department has been recognized for excellence in advertising and marketing for their standout work.
Keeping a Focus on Rare Disease During COVID-19
In this time of a viral pandemic, it is still important to keep a focus on rare diseases.
ISPE’s Position on Real World Evidence (RWE)
Read more about the February 2020 position on RWE from ISPE.
Lack of Label Alignment & Patient Safety Implications
Read the full article from UBC’s pharmacovigilance team in Drugs Real World Outcomes.
Future REMS Technology: Reduce Burden and Improve Safety
Learn more about UBC’s presentation at the 12th REMS Summit.
Risk Management Plan Development & Implementation
Listen to the full podcast from UBC with PharmaVOICE here.
Top Trends in Oncology Patient Support
Find out what access and adherence challenges patients will need to overcome in the evolving oncology market.
Are You Ready For Sentinel? | New RWE Safety Initiative
With continued investment in the RWE space, find out how to meet the needs of regulators, payers, and prescribers.
Immunogenicity: Meeting the Safety Reporting Requirements
Discover why it is imperative to assess the potential of therapeutic proteins throughout the product lifecycle.
